FBRX

FBRX

USD

Forte Biosciences Inc. Common Stock

$12.650-0.700 (-5.243%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$13.350

最高

$13.943

最低

$12.650

交易量

0.01M

公司基本面

市值

154.5M

行業

生物科技

國家

United States

交易統計

平均交易量

0.09M

交易所

NCM

貨幣

USD

52週範圍

最低 $4.11當前 $12.650最高 $28.68

相關新聞

BusinessWire

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,630,450 shares of its common

查看更多
Forte Biosciences Announces Pricing of $75 Million Public Offering
BusinessWire

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of

查看更多
Forte Biosciences Announces Proposed Public Offering
Analyst Upgrades

Chardan Capital Maintains Buy on Forte Biosciences, Maintains $61 Price Target

Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences with a Buy and maintains $61 price target.

查看更多
Chardan Capital Maintains Buy on Forte Biosciences, Maintains $61 Price Target
BusinessWire

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Phase 2 Celiac Disease Trial Initiating with Topline Readout Expected in 2026 Forte will be Hosting a Conference Call to Discuss the Results at 8:30 am ET Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX),

查看更多
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study